GLP-1 drugs are more than a health phenomenon—they are redefining pork’s trajectory. Producers who pivot to lean, unprocessed offerings can lead this transformation, while those anchored to fatty, processed products may struggle. The pork industry must decide: will it seize this opportunity to align with a leaner, healthier future?

Read the full article here.

Source: Connolly, Aidan. “Ozempic is Reshaping the Future of Pork.” Farm Journal’s PORK, 29 July 2025.